Patent US4357110A successfully refreshed from Google Patents.
Patent US476005A successfully refreshed from Google Patents.
Patent US4475424A successfully refreshed from Google Patents.
US4455291A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Accelerators for forming cationic technetium complexes useful as radiodiagnostic agents
Assignee: Bristol Myers Squibb Pharma Co
•
Filing: 1982-01-22
•
Granted: 1984-06-19
•
Expires: 2002-01-22
Abstract
Abstract A composition for preparing cationic lipophilic technetium complexes is described. The composition comprises an admixture of (a) an accelerator compound selected from the group of water-soluble organic bidentate ligands that are capable of coordinating with technetium to form a 4 to 6 member ring and (b) a target-seeking ligand, or aqueous salt thereof, having the structure indicated in formulas I, II or III. The accelerator compound has a weaker coordinating bond with technetium than the target-seeking ligand has with technetium.
Inventors
- 👤 Michael F. Tweedle
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 08:18
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0497; C; C07; C07F; C07F13/00; C07F13/005; C07F9/00; C07F9/66; C07F9/70; A61K2123/00
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
353 words
A composition for preparing cationic lipophilic technetium complexes for radiodiagnostic imaging, said composition comprising an admixture of (a) an accelerator compound selected from the group of water-soluble organic bidentate ligands that are capable of coordinating with technetium to form a 4 to 6 member ring and (b) a target-seeking ligand or aqueous salt thereof, having the following structure: ##STR9## wherein: i is an integer from 1 to 6; R, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently selected from hydrogen or substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups, and R plus R i may be taken together to form a cyclic compound or separately to form a linear compound; Y 1 , Y 2 , Y 3 , Y 4 , Y 5 and Y 6 are independently selected from substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; A 1 , A 2 , A 3 , A 4 , A 5 and A 6 are each, independently, a neutral donor atoms having a free-electron pair available for complexing with TC-99m or TC-99 to form a cationic complex; and k 1 , k 2 , k 3 , k 4 , k 5 and k 6 are each independently zero or one; or ##STR10## wherein: R, R', R" and R'" are independently selected from hydrogen or substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; A, A', A" and A'" are independently selected from the group of neutral donor atoms having a pair of electrons available for complexing with Tc-99m or TC-99 to form a cationic complex; B is an atom selected from the group of neutral donor atoms having a pair of electrons available for complexing with Tc-99m or TC-99 or from the elements listed in Group IV A of the periodic table; n, n', n" and n'" are independently the integer 1 or 2; and m is 0 or 1; said accelerator compound having a weaker coordinating bond with technetium than the target-seeking ligand.
Claim 2
Dependent Claim
353 words
A composition for preparing cationic lipophilic technetium complexes for radiodiagnostic imaging, said composition comprising an admixture of (a) an accelerator compound selected from the group of water-soluble organic bidentate ligands that are capable of coordinating with technetium to form a 4 to 6 member ring and (b) a target-seeking ligand or aqueous salt thereof, having the following structure: ##STR9## wherein: i is an integer from 1 to 6; R, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently selected from hydrogen or substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups, and R plus R i may be taken together to form a cyclic compound or separately to form a linear compound; Y 1 , Y 2 , Y 3 , Y 4 , Y 5 and Y 6 are independently selected from substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; A 1 , A 2 , A 3 , A 4 , A 5 and A 6 are each, independently, a neutral donor atoms having a free-electron pair available for complexing with TC-99m or TC-99 to form a cationic complex; and k 1 , k 2 , k 3 , k 4 , k 5 and k 6 are each independently zero or one; or ##STR10## wherein: R, R', R" and R'" are independently selected from hydrogen or substituted or unsubstituted alkyl, aryl, alkylaryl, arylalkyl, monocycloalkyl, polycycloalkyl, heterocyclic and carbocyclic groups; A, A', A" and A'" are independently selected from the group of neutral donor atoms having a pair of electrons available for complexing with Tc-99m or TC-99 to form a cationic complex; B is an atom selected from the group of neutral donor atoms having a pair of electrons available for complexing with Tc-99m or TC-99 or from the elements listed in Group IV A of the periodic table; n, n', n" and n'" are independently the integer 1 or 2; and m is 0 or 1; said accelerator compound having a weaker coordinating bond with technetium than the target-seeking ligand.
Claim 3
Dependent Claim
24 words
The composition of claim 1 wherein each A is selected from the group consisting of P, As, N, O, S, Sb, Se and Te.
Claim 4
Dependent Claim
14 words
The composition of claim 1 wherein said accelerator compound is capable of reducing technetium.
Claim 5
Dependent Claim
20 words
The composition of claim 1 wherein said accelerator is capable of coordinating with technetium to form a five member ring.
Claim 6
Dependent Claim
14 words
The composition of claim 1 wherein said accelerator compound is an alpha-hydroxy carboxylic acid.
Claim 7
Dependent Claim
14 words
The composition of claim 1 wherein said accelerator compound is an acidic 1,2-dihydroxy compound.
Claim 8
Dependent Claim
31 words
The composition of claim 6 wherein said accelerator compound is an enol, or a compound having a strong electron withdrawing group nearby the hydroxy groups so that the compound is acidic.
Claim 9
Dependent Claim
24 words
The composition of claim 7 wherein the electron withdrawing group is selected from --NO 2 , --Cl, --Br, --F, --I, or --CF 3 .
Claim 10
Dependent Claim
53 words
The composition of claim 1 wherein said target seeking ligand has the formula: ##STR11## wherein M and M' are arsenic, phosphorus, nitrogen, sulfur, oxygen, selenium, tellurium, or any combination of them, and R and R' are independently hydrogen, an alkyl group having from 1 to about 6 carbon atoms, or an aryl group.
Claim 11
Dependent Claim
79 words
The composition of claim 1 wherein said target-seeking ligand has the formula: R'.sub.2 M'--CX'.sub.2 CX.sub.2 --MR.sub.2 wherein M and M' are arsenic, phosphorus, nitrogen, sulfur, oxygen, selenium, tellurium, or any combination of them, and R and R' are independently hydrogen, an alkyl group having from 1 to about 6 carbon atoms, or an aryl group, and X and X' are independently selected from hydrogen, halide, or substituted or unsubstituted lower alkyl groups having 1 to about 6 carbon atoms.
Claim 12
Dependent Claim
55 words
The composition of claim 1 wherein said target-seeking ligand has the formula: ##STR12## wherein M, M' and M" are independently selected from arsenic, phosphorous, nitrogen, sulfur oxygen, selenium, and tellurium, and R, R' and R" are independently selected from hydrogen, halide, an alkyl group having 1 to about 6 carbon atoms, or an aryl group.
Claim 13
Dependent Claim
39 words
The composition of claim 1 wherein said target-seeking ligand has the formula: ##STR13## wherein A is P or As; and each R is independently H a lower alkyl group having from 1 to about 6 carbon atoms, or phenyl.
Claim 14
Dependent Claim
13 words
The composition of claim 1 wherein said target-seeking ligand has the formula: ##STR14##
Claim 15
Dependent Claim
29 words
The composition of claim 1 wherein said target-seeking ligand has the formula: ##STR15## wherein R is H or a lower alkyl group having 1 to about 6 carbon atoms.
Claim 16
Independent Claim
52 words
A method for making a cationic complex labelled with Tc-99m for radioscintigraphic imaging, said method comprising admixing 99m Tc-pertechnetate and the composition of any one of claims 1 through 14 and placing the resulting admixture in a constant temperature water bath for a period of time sufficient to form such labelled complex.
Claim 17
Dependent Claim
14 words
A lyophilized preparation comprising the composition of any one of claims 1 through 14.
Claim 18
Dependent Claim
18 words
A kit comprising a pre-sterilized, sealed vial containing the composition of any one of claims 1 through 14.
Claim 19
Dependent Claim
10 words
The kit of claim 17 wherein said composition is lyophilized.
Claim 20
Dependent Claim
28 words
The composition of claim 1 wherein said accelerator compound is selected from the group consisting of oxalic acid, ascorbic acid, tartaric acid, methylenediphosphonic acid, hydroxymethylenediphosphonic acid, or catechol.
Claim 21
Dependent Claim
23 words
The composition of claim 1 wherein said accelerator compound is a bidentate ligand capable of forming a five member chelate ring with technetium.
Claim 22
Dependent Claim
14 words
The composition of claim 1 wherein said accelerator compound is capable of reducing technetium.
Claim 23
Dependent Claim
13 words
The composition of claim 1 wherein said accelerator compound is a dicarboxylic acid.
Claim 24
Dependent Claim
13 words
The composition of claim 1 wherein said accelerator compound is a diphosphonic acid.
Claim 25
Dependent Claim
12 words
The composition of claim 1 wherein said accelerator compound is oxalic acid.
Claim 26
Dependent Claim
12 words
The composition of claim 1 wherein said accelerator compound is ascorbic acid.
Claim 27
Dependent Claim
17 words
The composition of any of claims 12, 13 or 14 wherein said accelerator compound is oxalic acid.
Claim 28
Dependent Claim
17 words
The composition of any of claims 12, 13 or 14 wherein said accelerator compound is ascorbic acid.
Claim 29
Dependent Claim
11 words
The composition of claim 1 wherein said target-seeking ligand is 1-dimethylphosphino-2-dimethylarseno-ethane.
Claim 30
Dependent Claim
71 words
A kit comprising a sterilized, sealed vial containing an admixture comprising oxalic acid or ascorbic acid and a target-seeking ligand having the structural formula R.sub.2 ACH.sub.2 CH.sub.2 AR.sub.2 wherein each R is independently selected from the group consisting of hydrogen, an alkyl group from 1 to about 6 carbon atoms and an aryl group; and each A independently selected from arsenic or phosphorus; or an acid addition salt of said ligand.
Claim 31
Dependent Claim
71 words
A kit comprising a sterilized, sealed vial containing an admixture comprising oxalic acid or ascorbic acid and a target-seeking ligand having the structural formula R.sub.2 ACH.sub.2 CH.sub.2 AR.sub.2 wherein each R is independently selected from the group consisting of hydrogen, an alkyl group from 1 to about 6 carbon atoms and an aryl group; and each A independently selected from arsenic or phosphorus; or an acid addition salt of said ligand.
Claim 32
Dependent Claim
11 words
The kit of claim 29 wherein said target-seeking ligand is bis(dimethylphosphino)ethane.
Claim 33
Dependent Claim
10 words
The kit of claim 29 wherein said admixture is lyophilized.
Claim 34
Dependent Claim
12 words
The kit of claim 31 wherein said target-seeking ligand is bis(dimethylphosphino)-ethane bis-bisulfate.
Claim 35
Dependent Claim
12 words
The kit of claim 31 wherein said target-seeking ligand is 1-dimethylphosphino-2-dimethylarseno-ethane bis-bisulfate.
References Cited (Backward Citations)
US2587805A
Cited
US3188345A
Cited
US3478035A
Cited
US3478036A
Cited
US3798241A
Cited
US3819670A
Cited
US4057615A
Cited
US3987157A
Cited
US4042677A
Cited
US4133872A
Cited
US4042676A
Cited
US4229427A
Cited
US4247534A
Cited
US4338248A
Cited
US4363793A
Cited
EP0038756A2
Cited
US4374821A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-06-19 | 1987-12-19 | 1988-06-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-06-19 | 1991-12-19 | 1992-06-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-06-19 | 1995-12-19 | 1996-06-19 | $7700.00 | Window Closed / Lapsed |